• Madrigal Pharmaceuticals shareholders adopted a 2026 Stock Plan at the June 17 annual meeting.
• Shareholders also adopted a 2026 Employee Stock Purchase Plan at the same meeting.
• The board adopted a Nonqualified Deferred Compensation Plan, effective Aug. 1, for selected executives and non-employee directors.
• Eligible employees can defer up to 60% of base salary, up to 95% of the following year’s cash performance bonus.
• Deferred balances are payable on separation from service in a lump sum or installments of up to 10 years, or at an elected in-service date.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Madrigal Pharmaceuticals Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001104659-26-075130), on June 17, 2026, and is solely responsible for the information contained therein.